These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3879645)

  • 1. Piroxicam serum levels in patients treated for rheumatic diseases.
    Bollet AJ
    Semin Arthritis Rheum; 1985 Feb; 14(3 Suppl 1):25-8. PubMed ID: 3879645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of acute gouty arthritis with piroxicam.
    Karachalios GN
    Clin Exp Rheumatol; 1985; 3(1):63-5. PubMed ID: 2579757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An evaluation of piroxicam, a new non-steroidal anti-inflammatory agent. A multicentre trial.
    Tweddell ED; Willcocks WA
    S Afr Med J; 1981 Jun; 59(25):915-6. PubMed ID: 7015542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Piroxicam capsules versus suppositories: a pharmacokinetic and clinical trial.
    Aärynen M; Palho J
    Arzneimittelforschung; 1986 Apr; 36(4):744-7. PubMed ID: 3521618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term experience with piroxicam in osteoarthritis.
    Zizic TM; Sutton JD; Stevens MB
    Semin Arthritis Rheum; 1985 Feb; 14(3 Suppl 1):14-9. PubMed ID: 3834587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicentre trial of piroxicam in ambulant rheumatology.
    Alvart R
    Eur J Rheumatol Inflamm; 1983; 6(1):99-105. PubMed ID: 6602706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement in gastrointestinal tolerability of the selective cyclooxygenase (COX)-2 inhibitor, meloxicam, compared with piroxicam: results of the Safety and Efficacy Large-scale Evaluation of COX-inhibiting Therapies (SELECT) trial in osteoarthritis.
    Dequeker J; Hawkey C; Kahan A; Steinbrück K; Alegre C; Baumelou E; Bégaud B; Isomäki H; Littlejohn G; Mau J; Papazoglou S
    Br J Rheumatol; 1998 Sep; 37(9):946-51. PubMed ID: 9783758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Piroxicam for the therapy of arthritis and rheumatism of the soft tissues (author's transl)].
    Knüsel O
    Schweiz Rundsch Med Prax; 1981 Dec; 70(51):2316-21. PubMed ID: 6949149
    [No Abstract]   [Full Text] [Related]  

  • 9. A double-blind, parallel study of tenoxicam and piroxicam in patients with osteoarthrosis.
    Bird HA; Hill J; Dixon JS; Looi D; Wright V
    Curr Med Res Opin; 1985; 9(8):529-35. PubMed ID: 3896662
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A parallel group comparison of tenoxicam and piroxicam in patients with ankylosing spondylitis.
    Bird HA; Le Gallez P; Astbury C; Looi D; Wright V
    Pharmatherapeutica; 1986; 4(7):457-62. PubMed ID: 3515371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experience with piroxicam in general practice: results of a German multicenter study on 18,888 patients.
    Langloh N
    Eur J Rheumatol Inflamm; 1983; 6(1):84-9. PubMed ID: 6861815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind multicentre trial of piroxicam and naproxen in osteoarthritis.
    Husby G; Holme I; Rugstad HE; Herland OB; Giercksky KE
    Clin Rheumatol; 1986 Jan; 5(1):84-91. PubMed ID: 3514082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of cimetidine on serum concentrations of piroxicam.
    Mailhot C; Dahl SL; Ward JR
    Pharmacotherapy; 1986; 6(3):112-7. PubMed ID: 3488542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Investigations on the clinical effect of the antirheumatic agent piroxicam (author's transl)].
    Mathies H; Wolff E
    MMW Munch Med Wochenschr; 1980 Jan; 122(3):99-102. PubMed ID: 6767932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A field study: piroxicam in arthrosis and soft tissue rheumatism. Results of a multicenter study].
    Knüsel O; Hinz G
    Schweiz Rundsch Med Prax; 1983 Sep; 72(37):1189-94. PubMed ID: 6356121
    [No Abstract]   [Full Text] [Related]  

  • 16. [Piroxicam (Felden), in the form of 20 mg suppositories, in the treatment of acute and chronic rheumatic diseases].
    Chantraine A; Van Ouwenaller C; Hinz G
    Rev Med Suisse Romande; 1984 Apr; 104(4):303-8. PubMed ID: 6610909
    [No Abstract]   [Full Text] [Related]  

  • 17. The efficacy of flurbiprofen versus piroxicam in the treatment of acute soft tissue rheumatism.
    Rosenthal M
    Curr Med Res Opin; 1984; 9(5):304-9. PubMed ID: 6397333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Side-effects of piroxicam (Feldene). A one-year material of 103 reports from Norway.
    Laake K; Kjeldaas L; Borchgrevink CF
    Acta Med Scand; 1984; 215(1):81-3. PubMed ID: 6695566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Piroxicam-beta-cyclodextrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in rheumatic diseases and pain states.
    Lee CR; Balfour JA
    Drugs; 1994 Dec; 48(6):907-29. PubMed ID: 7533698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Piroxicam--a step forward in the treatment of rheumatism].
    Fischer M
    Med Klin; 1980 Aug; 75(17):633-5. PubMed ID: 6997718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.